Evonik Industries AG and METabolic EXplorer (METEX) have agreed that Evonik will acquire a technology package from METEX to strengthen its biotechnology platform for amino acids, following an agreement signed in Paris. The package includes METEX's entire technology portfolio for the fermentative production of methionine, as well as patents, essential bacteria strains, and the inoLa brand. METEX considers that this agreement will underscore the relevance of METEX's alternative technologies and will strengthen its ability to commercialize its other technologies. The transaction also includes a back license agreement pertaining to certain patents to be transferred to Evonik; this agreement will allow METEX to continue using these patents for activities other than those relating to methionine. Furthermore, the companies intend to explore the possibility of a research and development cooperation agreement on the development of biotechnologically produced amino acids. The total consideration for the transfer of this technology, including a two-year transfer service agreement, amounts to EUR 45 million.